Hepatology

Ramadan fasting was linked to reduced liver fat and liver injury markers in adults with MASLD, according to new research.

A new machine learning model, CIRI, non-invasively predicted hepatic decompensation in advanced chronic liver disease as well as HVPG.

Fatty liver and high uric acid together were linked to nearly five-times the odds of impaired fasting glucose.

An experimental drug significantly reduced liver fat after 12 weeks in adults with MASH in a phase 2 clinical trial.

A systematic review found supervised exercise training improved functional capacity and muscle strength in adults with stable liver cirrhosis.

Time-restricted eating was linked to sustained improvements in liver fat and fibrosis-related measures in MASLD.

Drug-induced liver injury led to early termination of an ALG-020572 trial after four of eight patients with chronic HBV developed significant alanine aminotransferase elevations.

PEth was elevated in 11% of patients screened for MASLD trials, suggesting alcohol use warranting evaluation for possible MetALD or ALD.